Table 2.
Antecedent Pap test results and cervical cancer prevention procedures among women completing questionnaires (n=1588). N (%).
| HIV+ N=1123 | HIV− N=465 | P-valuea | |
|---|---|---|---|
| Total count of abnormal Pap results per patient | |||
| Median | 3.0 | 1.0 | <0.0001b |
| Ever had abnormal Pap result | 878 (78.2) | 268 (57.6) | <0.0001 |
| Grade of last Pap result | |||
| Negative | 858 (76.4) | 419 (90.1) | <0.0001 |
| ASCUSc | 183 (16.3) | 36 (7.8) | |
| LGSILd | 66 (5.9) | 7 (1.5) | |
| HGSILe | 16 (1.4) | 2 (0.4) | |
| Squamous cancer | 0 (0) | 1 (0.2) | |
| Grade of worst Pap test | |||
| Normal | 246 (21.9) | 198 (42.6) | <0.0001 |
| ASCUS | 376 (33.5) | 195 (41.9) | |
| LGSIL | 423 (37.7) | 62 (13.3) | |
| HGSIL | 78 (6.9) | 9 (2.0) | |
| Squamous cancer | 0 (0) | 1 (0.2) | |
| Total WIHS colposcopies per patient | |||
| Median | 2.0 | 1.0 | <0.0001b |
a
P-value obtained by using the chi-square test unless otherwise specified.
b
P-value obtained using the Wilcoxon two-sample test.
c
Atypical squamous cells of undetermined significance.
d
Low grade squamous intraepithelial lesion.
e
High grade squamous intraepithelial lesion.